洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2000033777】Effects of a live streaming Mindfulness Yoga - Practice Awareness through Cognitive-based Exercise (MY-PACE) Program on balance and gait for People with Parkinson’s Disease: A Randomised Controlled Trial

基本信息
登记号

ChiCTR2000033777

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-06-12

临床申请受理号

/

靶点

/

适应症

Parkinson's disease

试验通俗题目

Effects of a live streaming Mindfulness Yoga - Practice Awareness through Cognitive-based Exercise (MY-PACE) Program on balance and gait for People with Parkinson’s Disease: A Randomised Controlled Trial

试验专业题目

Effects of a live streaming Mindfulness Yoga - Practice Awareness through Cognitive-based Exercise (MY-PACE) Program on balance and gait for People with Parkinson’s Disease: A Randomised Controlled Trial

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To examine the comparative effects between Mindfulness Yoga – Practice Awareness through Cognitive-based Exercise (MY-PACE) and usual care service only for Chinese patients with mild-to-moderate PD, on the following physio-psycho-cognitive outcomes: a)functional mobility (primary outcome), b)perceived balance confidence (primary outcome), c)gait, d)PD-related motor symptoms, e)anxiety and depressive symptoms, f)mindfulness, g)cognitive function, and, h)HRQOL.

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

Eligible participants will be randomly assigned into one of the following conditions on 1:1 basis using a randomization table produced using computer-assisted random number generator.

盲法

Single-blinded

试验项目经费来源

University Fund

试验范围

/

目标入组人数

56

实际入组人数

/

第一例入组时间

2020-06-22

试验终止时间

2022-09-30

是否属于一致性

/

入选标准

To be eligible for inclusion, individuals must be (1) diagnosed with idiopathic PD (Hoehn and Yahr stage I-III); (2) aged >=18 years; (3) able to walk with or without an assistive device; (4) able to give written consent, and (5) have access to smartphone/ tablet device and Internet connection.;

排除标准

Individuals will be excluded if they: (1) are currently participating in any other behavioural or pharmacological trial; (2) have significant cognitive impairment as indicated by the Hong Kong Montreal Cognitive Assessment 5-min protocol (HK-MoCA), cutoff scores based on the age and education corrected normative data will be used [11] [12], or (3) have serious medical conditions except PD, or other contraindication to mild-to-moderate physical exertion that might limit their full participation (e.g. severe hearing or vision impairment, significant orthopaedic problems, etc.).;

研究者信息
研究负责人姓名
试验机构

香港大學李嘉誠醫學院護理學院

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品